Revolutionizing Cardiovascular Health with Nano Encapsulated Omega-3 Fatty Acids: A Nano-Solution Approach

Richa Gill,Mashael Al-Badr,Mohammad Alghouti,Nura Adam Mohamed,Haissam Abou-Saleh,Md Mizanur Rahman
DOI: https://doi.org/10.3390/md22060256
2024-05-31
Marine Drugs
Abstract:Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) offer diverse health benefits, such as supporting cardiovascular health, improving cognitive function, promoting joint and musculoskeletal health, and contributing to healthy aging. Despite their advantages, challenges like oxidation susceptibility, low bioavailability, and potential adverse effects at high doses persist. Nanoparticle encapsulation emerges as a promising avenue to address these limitations while preserving stability, enhanced bioavailability, and controlled release. This comprehensive review explores the therapeutic roles of omega-3 fatty acids, critically appraising their shortcomings and delving into modern encapsulation strategies. Furthermore, it explores the potential advantages of metal–organic framework nanoparticles (MOF NPs) compared to other commonly utilized nanoparticles in improving the therapeutic effectiveness of omega-3 fatty acids within drug delivery systems (DDSs). Additionally, it outlines future research directions to fully exploit the therapeutic benefits of these encapsulated omega-3 formulations for cardiovascular disease treatment.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problem this paper attempts to address is the treatment and prevention of cardiovascular diseases (CVD). Specifically, this review paper explores the role of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in cardiovascular health and evaluates their limitations, such as susceptibility to oxidation, low bioavailability, and potential side effects at high doses. The paper also introduces nanoencapsulation technology as a promising approach to address these issues while maintaining stability, enhancing bioavailability, and controlling release. In particular, the paper compares metal-organic framework nanoparticles (MOF NPs) with other commonly used nanoparticles in drug delivery systems (DDSs) to improve the therapeutic effects of ω-3 fatty acids and outlines future research directions to fully exploit the potential of these encapsulated ω-3 formulations in the treatment of cardiovascular diseases.